SUNPHARMA Statistics
Total Valuation
Sun Pharmaceutical Industries has a market cap or net worth of INR 4.38 trillion. The enterprise value is 4.25 trillion.
Market Cap | 4.38T |
Enterprise Value | 4.25T |
Important Dates
The next estimated earnings date is Thursday, October 31, 2024.
Earnings Date | Oct 31, 2024 |
Ex-Dividend Date | Jul 12, 2024 |
Share Statistics
Sun Pharmaceutical Industries has 2.40 billion shares outstanding. The number of shares has decreased by -0.17% in one year.
Shares Outstanding | 2.40B |
Shares Change (YoY) | -0.17% |
Shares Change (QoQ) | +0.48% |
Owned by Insiders (%) | 11.89% |
Owned by Institutions (%) | 27.88% |
Float | 1.04B |
Valuation Ratios
The trailing PE ratio is 42.13 and the forward PE ratio is 39.85. Sun Pharmaceutical Industries's PEG ratio is 2.87.
PE Ratio | 42.13 |
Forward PE | 39.85 |
PS Ratio | 8.89 |
PB Ratio | 6.88 |
P/FCF Ratio | n/a |
PEG Ratio | 2.87 |
Enterprise Valuation
EV / Earnings | 40.94 |
EV / Sales | 8.64 |
EV / EBITDA | 31.99 |
EV / EBIT | 39.38 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 4.88 |
Debt / EBITDA | 0.25 |
Debt / FCF | n/a |
Interest Coverage | 49.49 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Capital (ROIC) | 9.93% |
Revenue Per Employee | 11.44M |
Profits Per Employee | 2.42M |
Employee Count | 43,000 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +59.72% in the last 52 weeks. The beta is 0.55, so Sun Pharmaceutical Industries's price volatility has been lower than the market average.
Beta (5Y) | 0.55 |
52-Week Price Change | +59.72% |
50-Day Moving Average | 1,684.89 |
200-Day Moving Average | 1,504.53 |
Relative Strength Index (RSI) | 70.90 |
Average Volume (20 Days) | 1,898,115 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sun Pharmaceutical Industries had revenue of INR 492.09 billion and earned 103.89 billion in profits. Earnings per share was 43.31.
Revenue | 492.09B |
Gross Profit | 378.49B |
Operating Income | 108.45B |
Pretax Income | 119.88B |
Net Income | 103.89B |
EBITDA | 132.03B |
EBIT | 108.45B |
Earnings Per Share (EPS) | 43.31 |
Balance Sheet
The company has 190.90 billion in cash and 32.74 billion in debt, giving a net cash position of 158.16 billion or 65.92 per share.
Cash & Cash Equivalents | 190.90B |
Total Debt | 32.74B |
Net Cash | 158.16B |
Net Cash Per Share | 65.92 |
Equity (Book Value) | 671.06B |
Book Value Per Share | 265.35 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 76.92%, with operating and profit margins of 22.04% and 21.11%.
Gross Margin | 76.92% |
Operating Margin | 22.04% |
Pretax Margin | 24.36% |
Profit Margin | 21.11% |
EBITDA Margin | 26.83% |
EBIT Margin | 22.04% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 13.50, which amounts to a dividend yield of 0.74%.
Dividend Per Share | 13.50 |
Dividend Yield | 0.74% |
Dividend Growth (YoY) | -6.90% |
Years of Dividend Growth | 5 |
Payout Ratio | n/a |
Buyback Yield | 0.17% |
Shareholder Yield | 0.91% |
Earnings Yield | 2.37% |
FCF Yield | n/a |
Stock Splits
The last stock split was on July 29, 2013. It was a forward split with a ratio of 2.
Last Split Date | Jul 29, 2013 |
Split Type | Forward |
Split Ratio | 2 |